Aditya Bardia
Impact in
- Oncology top 0.05%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- Cancer Treatment and Pharmacology
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
- Oncology 345
- HER2/EGFR in Cancer Research 166
- Cancer Treatment and Pharmacology 136
- Cancer-related Molecular Pathways 24
- Cancer Research 176
- Breast Cancer Treatment Studies 100
- Cancer Genomics and Diagnostics 74
- Co-authors
- Laura M. SpringSteven J. IsakoffMehmet TonerDaniel A. HaberShyamala MaheswaranShannon L. StottBen S. WittnerBeverly Moy
- Journals
- Journal of Clinical Oncology (136 papers)Cancer Research (111 papers)Annals of Oncology (33 papers)Clinical Cancer Research (17 papers)Breast Cancer Research and Treatment (17 papers)
- Partner nations
- United StatesSpainFrance
In The Last Decade
Aditya Bardia
456 papers receiving 15.9k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Oncology 10.9k
- Cancer Research 5.0k
- Pulmonary and Respiratory Medicine 5.4k
- Genetics 1.1k
- Radiology, Nuclear Medicine and Imaging 1.8k
Countries citing papers authored by Aditya Bardia
This map shows the geographic impact of Aditya Bardia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aditya Bardia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aditya Bardia more than expected).
Fields of papers citing papers by Aditya Bardia
This network shows the impact of papers produced by Aditya Bardia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aditya Bardia. The network helps show where Aditya Bardia may publish in the future.
Co-authors
The 25 scholars most cited alongside Aditya Bardia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 19 | |
| 5 | 2023 | 67 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 7 | |
| 8 | 2021 | 12 | |
| 9 | 2021 | 35 | |
| 10 | 2021 | 67 | |
| 11 | Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells Hit paper breakdown → | 2021 | 236 |
| 12 | 2021 | 33 | |
| 13 | 2019 | 47 | |
| 14 | 2018 | 55 | |
| 15 | 2018 | 78 | |
| 16 | 2017 | 139 | |
| 17 | 2015 | 168 | |
| 18 | Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis Hit paper breakdown → | 2014 | 1786 |
| 19 | Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition Hit paper breakdown → | 2013 | 1928 |
| 20 | Declining sex ratio: role of society, technology and government regulation in Faridabad district, Haryana. | 2004 | 14 |
About Aditya Bardia
Aditya Bardia is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 481 papers that have together received 16.1k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (246 papers), HER2/EGFR in Cancer Research (166 papers), Cancer Treatment and Pharmacology (136 papers), Breast Cancer Treatment Studies (100 papers), Cancer Genomics and Diagnostics (74 papers), Estrogen and related hormone effects (41 papers), Lung Cancer Treatments and Mutations (32 papers) and Cancer-related Molecular Pathways (24 papers). The work is most often cited by research in Oncology (10.9k citations), Cancer Research (5.0k citations), Pulmonary and Respiratory Medicine (5.4k citations), Genetics (1.1k citations) and Radiology, Nuclear Medicine and Imaging (1.8k citations). Aditya Bardia has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Laura M. Spring, Steven J. Isakoff, Mehmet Toner, Daniel A. Haber, Shyamala Maheswaran, Shannon L. Stott, Ben S. Wittner, Beverly Moy, Sridhar Ramaswamy and Maria Donaldson Collier. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Clinical Cancer Research and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.